Search

everythinglearnresearchcommunity

for

Search:↓

Accurate diagnosis is crucial to distinguish between PCOS and rare ovarian tumors in teens with similar symptoms.

PCOS women have more arm fat and higher insulin resistance and glucose levels than non-PCOS women.

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

A young woman had a rare tumor causing high male hormone levels and symptoms like excessive hair and acne. After removing the tumor, her hormone levels returned to normal. Early diagnosis is important.

The combination therapy reduced hirsutism in women with PCOD and was well-tolerated.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

The guideline emphasizes a multidisciplinary approach and informed consent for gender-affirming hormone treatment, with regular follow-ups and individualized care.

A young girl's hyperandrogenism was caused by an adrenocortical adenoma, diagnosed and treated through detailed evaluations.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Acne in adult women may occur alone or with signs of high male hormones.

Some hormone treatments might raise breast cancer risk, while others don't seem to.

Many acne patients have high androgen levels, which may lead to PCOD, but treatments like oral contraceptives and antiandrogens can help.

Targeting glycolysis may help treat PCOS by improving insulin sensitivity and ovarian function.

The patient's long-term symptoms were due to Sheehan's syndrome, which improved with hormone therapy.

Testosterone therapy may help women with low sexual desire after surgical menopause.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

Certain health factors can worsen fertility treatment results in women with PCOS.

Women with premature ovarian insufficiency have a worse cardiovascular risk profile than premenopausal women.

Women with more 3α,17β-androstanediol glucuronide compared to sex hormone binding globulin are more likely to have female pattern baldness.

PCOS is a common hormonal disorder in women, treated with lifestyle changes and medications like hormonal contraceptives and metformin.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

The patient with a misplaced pituitary gland and interrupted pituitary stalk is being treated with hormone replacement.

Taiwanese women with PCOS experience different symptoms based on age, with younger women facing more hormone imbalances and older women dealing with more metabolic issues.

Testosterone in older women can increase bone density, muscle mass, fat mass, improve memory, and boost libido, but may cause nipple color changes.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

The conclusion is to diagnose PCOS with just hyperandrogenism and irregular periods, and treat with lifestyle changes and basic medications.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

Oocyte retrieval is possible for transgender men on testosterone therapy without affecting fertility outcomes.

Females with 5 alpha-reductase-2 deficiency have less body hair, no acne, normal fertility, and delayed menarche.